August 20, 2012
The Ministry of Health, Labor and Welfare (MHLW) on August 16 designated as orphan drugs four products including Eisai’s lenvatinib mesylate, which is expected to be indicated for thyroid cancer. The Evaluation and Licensing Division at the Pharmaceutical and Food...read more